Predictive immune markers in advanced melanoma patients treated with ipilimumab
Myeloid-derived suppressor cells (MDSCs) and chronic inflammatory factors induce immunosuppression and disease progression in advanced melanoma patients. They could serve as important markers allowing the identification of patients with high risk of melanoma progression as well as the detection of t...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
28 Jun 2016
|
| In: |
OncoImmunology
Year: 2016, Volume: 5, Issue: 6 |
| ISSN: | 2162-402X |
| DOI: | 10.1080/2162402X.2016.1158901 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1080/2162402X.2016.1158901
|
| Author Notes: | Viktor Umansky, Jochen Utikal and Christoffer Gebhardt |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1679764853 | ||
| 003 | DE-627 | ||
| 005 | 20230427134455.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191024s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/2162402X.2016.1158901 |2 doi | |
| 035 | |a (DE-627)1679764853 | ||
| 035 | |a (DE-599)KXP1679764853 | ||
| 035 | |a (OCoLC)1341249282 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Umansky, Viktor |d 1955- |e VerfasserIn |0 (DE-588)102885756X |0 (DE-627)731733207 |0 (DE-576)376300078 |4 aut | |
| 245 | 1 | 0 | |a Predictive immune markers in advanced melanoma patients treated with ipilimumab |c Viktor Umansky, Jochen Utikal and Christoffer Gebhardt |
| 264 | 1 | |c 28 Jun 2016 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.10.2019 | ||
| 520 | |a Myeloid-derived suppressor cells (MDSCs) and chronic inflammatory factors induce immunosuppression and disease progression in advanced melanoma patients. They could serve as important markers allowing the identification of patients with high risk of melanoma progression as well as the detection of those patients who may benefit from the therapy with ipilimumab. | ||
| 650 | 4 | |a Eosinophils | |
| 650 | 4 | |a HMGB1 | |
| 650 | 4 | |a ipilimumab | |
| 650 | 4 | |a melanoma | |
| 650 | 4 | |a myeloid-derived suppressor cells | |
| 650 | 4 | |a predictive markers | |
| 650 | 4 | |a S100A8/A9 | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e VerfasserIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 aut | |
| 700 | 1 | |a Gebhardt, Christoffer |d 1976- |e VerfasserIn |0 (DE-588)13051151X |0 (DE-627)503031666 |0 (DE-576)298240289 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoImmunology |d Abingdon : Taylor & Franics, 2012 |g 5(2016,6) Artikel-Nummer e1158901, 3 Seiten |h Online-Ressource |w (DE-627)683365428 |w (DE-600)2645309-5 |w (DE-576)356728366 |x 2162-402X |7 nnas |a Predictive immune markers in advanced melanoma patients treated with ipilimumab |
| 773 | 1 | 8 | |g volume:5 |g year:2016 |g number:6 |g extent:3 |a Predictive immune markers in advanced melanoma patients treated with ipilimumab |
| 856 | 4 | 0 | |u https://doi.org/10.1080/2162402X.2016.1158901 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20191024 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 13051151X |a Gebhardt, Christoffer |m 13051151X:Gebhardt, Christoffer |d 60000 |d 61900 |e 60000PG13051151X |e 61900PG13051151X |k 0/60000/ |k 1/60000/61900/ |p 3 |y j | ||
| 998 | |g 1026463750 |a Utikal, Jochen |m 1026463750:Utikal, Jochen |d 60000 |e 60000PU1026463750 |k 0/60000/ |p 2 | ||
| 998 | |g 102885756X |a Umansky, Viktor |m 102885756X:Umansky, Viktor |d 60000 |d 61900 |d 140000 |e 60000PU102885756X |e 61900PU102885756X |e 140000PU102885756X |k 0/60000/ |k 1/60000/61900/ |k 0/140000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1679764853 |e 3526979472 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","display":"Umansky, Viktor","given":"Viktor","roleDisplay":"VerfasserIn","family":"Umansky"},{"roleDisplay":"VerfasserIn","family":"Utikal","role":"aut","display":"Utikal, Jochen","given":"Jochen"},{"roleDisplay":"VerfasserIn","family":"Gebhardt","given":"Christoffer","display":"Gebhardt, Christoffer","role":"aut"}],"physDesc":[{"extent":"3 S."}],"name":{"displayForm":["Viktor Umansky, Jochen Utikal and Christoffer Gebhardt"]},"relHost":[{"part":{"text":"5(2016,6) Artikel-Nummer e1158901, 3 Seiten","issue":"6","volume":"5","extent":"3","year":"2016"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedKey":"2012","dateIssuedDisp":"2012-","publisher":"Taylor & Franics ; Landes Bioscience"}],"note":["Gesehen am 13.12.2022"],"disp":"Predictive immune markers in advanced melanoma patients treated with ipilimumabOncoImmunology","title":[{"title_sort":"OncoImmunology","title":"OncoImmunology"}],"id":{"zdb":["2645309-5"],"eki":["683365428"],"issn":["2162-402X"]},"titleAlt":[{"title":"Onco Immunology"}],"pubHistory":["1.2012 -"],"recId":"683365428"}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"28 Jun 2016"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1679764853","id":{"eki":["1679764853"],"doi":["10.1080/2162402X.2016.1158901"]},"title":[{"title_sort":"Predictive immune markers in advanced melanoma patients treated with ipilimumab","title":"Predictive immune markers in advanced melanoma patients treated with ipilimumab"}],"note":["Gesehen am 24.10.2019"]} | ||
| SRT | |a UMANSKYVIKPREDICTIVE2820 | ||